Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval

Jan 7 (Reuters) – The U.S. Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd (4523.T) and Biogen Inc (BIIB.O) for patients in the earliest stage…
Read More

Tami Fleishman